Sort   by:  
 Page size 
ProteomicsComparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines
Vector-based SARS-CoV-2 vaccines such as AstraZeneca's ChAdOx1 nCoV-19 have been associated with vaccine-induced thrombosis (TTS/VITT). We studied ChAdOx1 nCov-19 (AstraZeneca) and Ad26.COV2.S (Johnson & Johnson) and compared the vaccines using proteomics with mass spectrometric measurements. We cou...
ORGANISM(S): Homo sapiens (Human) 
2023-05-04 | PXD027344 | Pride
Ad26.cov2.s Sars-cov-2 Vector vaccines Chadox1 
UnknownAdenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses.
Not available
S-EPMC9481145 | biostudies-literature
UnknownVaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
Not available
S-EPMC7532807 | biostudies-literature
UnknownDevelopments in Viral Vector-Based Vaccines.
Not available
S-EPMC4494222 | biostudies-literature
UnknownSequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets.
Not available
S-EPMC9664441 | biostudies-literature
UnknownUnique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.
Not available
S-EPMC5204448 | biostudies-literature
GenomicsBulk RNA sequencing study of Rhesus macaques given Modified versions of the RhCMV/SIV vector-based vaccines.
Bulk RNA sequencing study of Rhesus macaques given Modified versions of the RhCMV/SIV vector-based vaccines.
PRJNA1237226 | ENA
UnknownAdenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines.
Not available
S-EPMC7712206 | biostudies-literature
GenomicsBulk RNA sequencing study of female rhesus macaques given Modified versions of the RhCMV/SIV vector-based vaccines.
Bulk RNA sequencing study of female rhesus macaques given Modified versions of the RhCMV/SIV vector-based vaccines.
PRJNA1237219 | ENA
UnknownAirborne transmission-mediated delivery of a live-attenuated influenza virus vector-based intranasal COVID-19 vaccine protects Syrian hamsters against SARS-CoV-2 challenge.
Not available
S-EPMC12808143 | biostudies-literature
Sort   by:  
 Page size